Skip To Main Content
Lilly
Menu closed
Lilly
  • Medical Home
    • Medical Information
Chat Click to chat
Question Submit a question

Information Request

Lilly Rep Request

Expand contact lilly
Lilly

You are now leaving the LillyMedical website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company does not control, influence, or endorse this site, and the opinions, claims or comments expressed on this site should not be attributed to Eli Lilly and Company. Eli Lilly and Company is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

  1. Home Medical Right
  2. Medical Information Right
  3. Omvoh ® ▼ (mirikizumab) Right
  4. How to store Omvoh® (mirikizumab) vials and diluted solution
Search mirikizumab information
Search Medical Information


Tips for searching:

• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences

Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.

Omvoh ® ▼ (mirikizumab)

This information is intended for UK registered healthcare professionals only in response to your search for information. For current information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk

Back to search result(s)

How to store Omvoh® (mirikizumab) vials and diluted solution

Store unopened vials at 2 - 8°C in the outer carton to protect them from light. Do not freeze. The diluted solution should be administered immediately.

UK_cFAQ_MIR5000_STORAGE_OF_VIALS_DILUTED_SOLUTION
UK_cFAQ_MIR5000_STORAGE_OF_VIALS_DILUTED_SOLUTIONen-GB

How to store unopened vials 

Store in a refrigerator (2 ºC – 8 ºC).

Do not freeze.

Keep the vial in the outer carton in order to protect from light.1

What is the shelf-life?

The shelf-life of an unopened vial is 2 years when stored at 2 ºC – 8 ºC in its original carton until use.1,2

How to store opened/ in-use vials and diluted solution

The product does not contain a preservative therefore,2 from a microbiological point of view, the product should be used immediately.1

  • If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 °C, unless dilution has taken place in controlled and validated aseptic conditions.1

Keep the diluted solution away from direct heat or light. 1

Do not freeze the diluted solution.1

The vial is in-use starting at the time the vial stopper is first punctured.  Once the vial is “in-use” the Omvoh solution must be used to prepare the diluted dosing solution.2

Storage conditions after dilution under aseptic conditions

It is recommended to start the infusion immediately after dilution. If not immediately used, the diluted solution prepared with sodium chloride 9 mg/mL (0.9 %) solution for injection may be stored

  • refrigerated (2 ºC – 8 ºC) for not more than 96 hours or
  • at room temperature not exceeding 25 ºC for not more than 10 hours (total time must not exceed 96 hours) starting from the time of vial puncture.3

The diluted infusion solution prepared with 5 % glucose must be used within 48 hours, of which not more than 5 hours are permitted at nonrefrigerated temperature not to exceed 25 °C, starting at the time of vial puncture.3

References

1Omvoh 300 mg concentrate for solution for infusion [summary of product characteristics] Eli Lilly Nederland B.V., The Netherlands (UK)

2Data on file, Eli Lilly and Company and/or one of its subsidiaries.

3Omvoh 300 mg concentrate for solution for infusion [Package Information Leaflet] Eli Lilly Nederland B.V., The Netherlands (UK)

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Date of Last Review: 12 June 2023

Was this answer helpful?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms and conditions
  • Privacy Policy & Cookies
  • Accessibility Information
  • Cookie settings

    MI-LM-UK-1012 May-2025 | ® Registered Trademark of Eli Lilly and Company | © Eli Lilly and Company 2025.

    This site is published by Eli Lilly and Company Ltd and is intended for Healthcare Professionals in the United Kingdom

    Lilly